(Q39747931)

14 September 2017

title

Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E. (English)

1 reference

14 September 2017

1 reference

1 reference

P Soubeyran

5

0 references

author name string

C Andrieu

1

1 reference

14 September 2017

D Taieb

2

1 reference

14 September 2017

V Baylot

3

1 reference

14 September 2017

S Ettinger

4

1 reference

14 September 2017

A De-Thonel

6

1 reference

14 September 2017

C Nelson

7

1 reference

14 September 2017

C Garrido

8

1 reference

14 September 2017

A So

9

1 reference

14 September 2017

L Fazli

10

1 reference

14 September 2017

F Bladou

11

1 reference

14 September 2017

M Gleave

12

1 reference

14 September 2017

J L Iovanna

13

1 reference

14 September 2017

P Rocchi

14

1 reference

14 September 2017

language of work or name

English

0 references

publication date

18 January 2010

1 reference

14 September 2017

1 reference

14 September 2017

volume

29

1 reference

14 September 2017

issue

13

1 reference

14 September 2017

page(s)

1883-1896

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2009.479

14 September 2017

exact match

0 references

cites work

4E-binding protein 1: a key molecular "funnel factor" in human cancer with clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Identification of the ubiquitin-proteasome pathway in the regulation of the stability of eukaryotic elongation factor-2 kinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

When translation meets transformation: the mTOR story

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Treatment options in hormone-refractory metastatic prostate carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Hormone-refractory prostate cancer: a shifting paradigm in treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

HSP27 and HSP70: potentially oncogenic apoptosis inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Targeting the eukaryotic translation initiation factor 4E for cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Cell cycle-dependent phosphorylation of the translational repressor eIF-4E binding protein-1 (4E-BP1)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Gastrosplenic fistula from Hodgkin's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Interaction between beta-amyloid and lens alphaB-crystallin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

The case for early chemotherapy for the treatment of metastatic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

eIF4E--from translation to transformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Small-Molecule Targeting of Heat Shock Protein 90 Chaperone Function: Rational Identification of a New Anticancer Lead

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Lesion macrophages are a key target for the antiatherogenic effects of LXR agonists

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

The proteasome--an emerging therapeutic target in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Ubiquitination and proteasome-dependent degradation of human eukaryotic translation initiation factor 4E.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Growth inhibition of head and neck squamous carcinoma cells by small interfering RNAs targeting eIF4E or cyclin D1 alone or combined with cisplatin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Eukaryotic translation initiation factor 4E is a cellular target for toxicity and death due to exposure to cadmium chloride

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

HSP27 favors ubiquitination and proteasomal degradation of p27Kip1 and helps S-phase re-entry in stressed cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

mTOR signaling: implications for cancer and anticancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Ubiquitin enters the new millennium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Rational design of shepherdin, a novel anticancer agent.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Regulation of cap-dependent translation by eIF4E inhibitory proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Molecular analysis integrating different pathways associated with androgen-independent progression in LuCaP 23.1 xenograft

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.479

31 March 2020

Identifiers

DOI

10.1038/ONC.2009.479

1 reference

14 September 2017

1 reference